4.5 Article

Haplotype selection as an adaptive mechanism in the protozoan pathogen Leishmania donovani

Journal

NATURE ECOLOGY & EVOLUTION
Volume 1, Issue 12, Pages 1961-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41559-017-0361-x

Keywords

-

Funding

  1. European Union 7th Framework Programme (EU FP7) [222895]
  2. Belgian Science Policy Office (TRIT) [P7/41]
  3. Department of Economy, Science and Innovation in Flanders (ITM-SOFIB)
  4. Flemish Fund for Scientific Research [G.0.B81.12]
  5. Plan Nacional [BFU2011-28575]
  6. Center for Genomic Regulation (CRG)
  7. Spanish Ministry of Economy and Competitiveness
  8. Centra de Excelencia Severe Ochoa [SEV-2012-0208]
  9. Institut Pasteur International Department strategic fund
  10. Agence Nationale de la Recherche (ANR) within the framework of the apos
  11. Investissements dapos
  12. avenirapos
  13. programme [ANR-11-LABX-0024-01]
  14. EU FP7 (Kaladrug-R) [222895]

Ask authors/readers for more resources

The parasite Leishmania donovani causes a fatal disease termed visceral leishmaniasis. The process through which the parasite adapts to environmental change remains largely unknown. Here we show that aneuploidy is integral for parasite adaptation and that karyotypic fluctuations allow for selection of beneficial haplotypes, which impact transcriptomic output and correlate with phenotypic variations in proliferation and infectivity. To avoid loss of diversity following karyotype and haplotype selection, L. donovani utilizes two mechanisms: polyclonal selection of beneficial haplotypes to create coexisting subpopulations that preserve the original diversity, and generation of new diversity as aneuploidy-prone chromosomes tolerate higher mutation rates. Our results reveal high aneuploidy turnover and haplotype selection as a unique evolutionary adaptation mechanism that L. donovani uses to preserve genetic diversity under strong selection. This unexplored process may function in other human diseases, including fungal infection and cancer, and stimulate innovative treatment options.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available